These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13298720)

  • 1. The chemotherapeutic agents and the resistance against tubercle bacilli. II. The inactivation of isoniazid by a charcoal liquid medium and the tuberculocidal effect of the drug.
    SHOJI M
    Sci Rep Res Inst Tohoku Univ Med; 1955 Oct; 6(3):301-8. PubMed ID: 13298720
    [No Abstract]   [Full Text] [Related]  

  • 2. The chemotherapeutic agents and the resistance against tubercle bacilli. I. The inactivation and the tuberculocidal effect of isoniazid.
    SHOJI M
    Sci Rep Res Inst Tohoku Univ Med; 1955 Jan; 6(1):97-106. PubMed ID: 13246660
    [No Abstract]   [Full Text] [Related]  

  • 3. The chemotherapeutic agents and their resistance against tubercle bacilli. III. Hemin starch liquid medium for the cultivation of isoniazid-susceptible and resistant tubercle bacilli.
    SHOJI M
    Sci Rep Res Inst Tohoku Univ Med; 1955 Oct; 6(3):377-90. PubMed ID: 13298725
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the development of resistance of tubercle bacilli to isoniazid.
    VENNESLAND K
    Trans Annu Meet Natl Tuberc Assoc; 1953; 49():183-91. PubMed ID: 13136314
    [No Abstract]   [Full Text] [Related]  

  • 5. The action of chemotherapeutic agents of intracellular tubercle bacilli.
    KAWAMORITA K
    Sci Rep Res Inst Tohoku Univ Med; 1955 Oct; 6(3):359-75. PubMed ID: 13298724
    [No Abstract]   [Full Text] [Related]  

  • 6. Developments in the laboratory: the growth requirements and pathogenic properties of isoniazid-resistant tubercle bacilli.
    MIDDLEBROOK G; COHN ML; SCHAEFER WB; KOVITZ C
    Trans Annu Meet Natl Tuberc Assoc; 1954; 96(50th Meeting):239-40. PubMed ID: 13216871
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problem of virulence of chemoresistant tubercle bacilli. III. Mixtures of sensitive and isoniazid resistant single colony cultures].
    MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1955; 113(1):62-74. PubMed ID: 14389184
    [No Abstract]   [Full Text] [Related]  

  • 8. A new method for determining the growth rate of M. tuberculosis and its application to the study of the toxic effect of streptomycin and isonicotinic hydrazide acid on tubercle bacilli.
    BEKIERKUNST A; SZULGA T
    Schweiz Z Pathol Bakteriol; 1954; 17(1):47-72. PubMed ID: 13156590
    [No Abstract]   [Full Text] [Related]  

  • 9. Attenuation of highly isoniazid-resistant tubercle bacilli.
    HIRANO N; NAKANISHI K; FUKUNAGA K
    Yokohama Med Bull; 1955 Aug; 6(4):196-202. PubMed ID: 13300158
    [No Abstract]   [Full Text] [Related]  

  • 10. [Some observations on the resistance of tubercle bacilli to isoniazid].
    STAUBLI C; STEINITZ KH
    Schweiz Z Tuberk; 1953; 10(4):339-42. PubMed ID: 13135502
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the virulence of chemoresistant tubercle bacilli. II. Tubercle bacilli which have become resistant to isoniazid in vivo].
    MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 110(6):538-46. PubMed ID: 13159801
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenicity of isoniazid-resistant tubercle bacilli and prophylaxis of tuberculosis in children.
    RIST N
    Am Rev Tuberc; 1956 Aug; 74(2 Part 2):75-89; discussion, 90-9. PubMed ID: 13340168
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients.
    MIDDLEBROOK G; COHN ML; SCHAEFER WB
    Am Rev Tuberc; 1954 Nov; 70(5):852-72. PubMed ID: 13207636
    [No Abstract]   [Full Text] [Related]  

  • 14. Bactericidal activity of streptomycin and isoniazid against tubercle bacilli.
    SINGH B; MITCHISON DA
    Br Med J; 1954 Jan; 1(4854):130-2. PubMed ID: 13106497
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility to isoniazid and pathogenicity of tubercle bacilli.
    BLOCH H; WIDELOCK D; PEIZER LR
    Am Rev Tuberc; 1953 Nov; 68(5):734-8. PubMed ID: 13104886
    [No Abstract]   [Full Text] [Related]  

  • 16. The virulence of isoniazid resistant tubercle bacilli, recovered from patients during treatment.
    MEISSNER G
    Dis Chest; 1954 Jul; 26(1):15-26. PubMed ID: 13173335
    [No Abstract]   [Full Text] [Related]  

  • 17. The action of isoniazid-streptomycin and isoniazid-dihydrostreptomycin mixtures on tubercle bacilli.
    BERCZELLER A; FRANK G; PAPA CJ
    Q Bull Sea View Hosp; 1953 Oct; 14(4):174-85. PubMed ID: 13112383
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of isoniazid on growing and resting tubercle bacilli.
    SCHAEFER WB
    Am Rev Tuberc; 1954 Jan; 69(1):125-7. PubMed ID: 13114634
    [No Abstract]   [Full Text] [Related]  

  • 19. Varied degrees of isoniazid resistance within strains of tubercle bacilli from sputum and pulmonary cavities.
    STEWART SM
    Am Rev Tuberc; 1956 Mar; 73(3):390-405. PubMed ID: 13292708
    [No Abstract]   [Full Text] [Related]  

  • 20. Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
    MIDDLEBROOK G
    Am Rev Tuberc; 1954 Mar; 69(3):471-2. PubMed ID: 13138881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.